FROM PUBLIC EVENTS · 2026-11-18

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Has licensed several preclinical ADCs to global drugmakers, and licensed assets have entered Phase 1 in the US and Korea. Also seen: Global approvals · expansion

  • Its half-year report disclosed US FDA clearance of the ODS025 Phase 1 IND. Source

Roles often seen at this stageResearch & development · BD & licensing · Clinical & PV

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-18

AimedBio

An antibody-drug conjugate (ADC) developer spun off from Samsung Medical Center in 2018, using patient-derived cell and model platforms; listed on KOSDAQ in December 2025.

ODS025

Phase 1

A solid-tumour ADC licensed to Boehringer Ingelheim in a deal worth up to USD 991 million; US FDA cleared its Phase 1 IND in June 2026.

AMB303

Stage unconfirmed

A ROR1-targeted ADC co-developed with and licensed to SK Plasma, in IND-enabling preclinical studies.

Completion reported

ODS025, licensed to Boehringer Ingelheim, received US FDA clearance of its Phase 1 IND.

Official role guide

AimedBio careers

Current availability unconfirmed

Observed 2026-11-18

Work
Unconfirmed — The official careers page was found, but postings and duties were not read in this check.
Experience & requirements
Unconfirmed — Requirements were not checked on the official careers page.

Information from a role guide does not establish a current vacancy.

Sources & coverage 4

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 에임드바이오, 코스닥 상장…"韓 바이오업계 새로운 기준 제시" ↗전자신문 · Published 2025-12-04 · Sources checked 2026-11-18 · Original unavailable
  2. 에임드바이오, 베링거 기술수출 ADC…美 FDA 임상 1상 승인 ↗바이오북 · Published 2026-08-12 · Sources checked 2026-11-18 · Original unavailable
  3. 에임드바이오 국산 ADC 신약 'AMB302' 임상 돌입 ↗헬스코리아뉴스 · Published 2025-04-17 · Sources checked 2026-11-18 · Original unavailable
  4. 에임드바이오 채용 ↗에임드바이오 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable